About Claire

I have over 30 years experience in trade marks, in both external practices, the best known of which is Grant Spencer Caisley & Porteous, and in-house at Glaxo Wellcome (now GlaxoSmithKline), when I was responsible for the worldwide HIV and anti-viral trade mark portfolio for the entire group.

​

I am highly-qualified for this work - my law degree is from London University (Queen Mary), the noted specialist for IP Law. Professor Jeremy Philips himself taught me. And, in 2013, he said “Claire Lazenby is a very fine exponent of the subtleties of trade mark practice” (Katpost, 23 December 2013). And I also specialised at QM in EEC law. Which, with the advent of the EU trade mark system in 1996, I have put to good use every day since then. And, now with Brexit, is even more helpful.

 

I am a Fellow of the Chartered Institute of Trade Mark Attorneys, www.citma.org.uk by examination. Not everyone who works in trade mark law has passed this exam. It’s very tough.

I have edited case law bulletins for both this Institute and the European Communities Trade Mark Association www.ecta.org. I have contributed to the Community Trade Marks Handbook and Trade Mark Law: A Practical Anatomy.

 

I lobby for reforms for trade mark law, both in my personal capacity and also through ECTA, for whom I served the eight-year term of Council Member 2012-2022 and was also on  ECTA’s Harmonisation Committee, on the Committee Link to WIPO, and was also one of ECTA’s Madrid Task Managers. I’ve contributed comments and drafts for both the 2015 EU Regulation and the draft implementing regulations. I currently sit on the UK CITMA WIPO Committee.

 

I am regulated by the Intellectual Property Regulation Board www.ipreg.org.uk

​

I am insured by PAMIA, for £5m, which is well above the minimum recommended by IPReg.